15 results
IV Fluids - Comparison Table
Fluid - pH - Osm - Na - Cl - Other
 •
IV Fluids - Comparison ... pH - Osm - Na - Cl ... EmmGeezee #IV ... #Fluids #IVF #Comparison ... #Table #pharmacology
Antibiogram - Antibiotic Resistance Table for Severe Multidrug Resistant Bacteria

ESBL Enterobacteriaceae
Carbapenem-Resistant Enterobacteriaceae
MDR Pseudomonas Aeruginosa
Carbapenem-Resistant Acinetobacter

Adapted from
Antibiogram - Antibiotic ... ABsteward #MDR #Antibiogram ... #Antibiotic #Resistance ... InfectiousDiseases #Resistant #Comparison ... #Table #Pharmacology
Parenteral Antimicrobial Treatment of Common Microorganisms Causing Native Vertebral Osteomyelitis - IDSA 
Staphylococci, oxacillin susceptible
Staphylococci, oxacillin
Osteomyelitis - IDSA ... #Parenteral #IV ... #Antibiotics #Osteomyelitis ... management #treatment #pharmacology ... #idsa
IV Fluid Composition and Effects on Plasma
0.9% Saline
Ringer's Lactate
Balanced Crystalloid

#IVFluid #Composition #Plasma #comparison #Effects #nephrology #pharmacology
IV Fluid Composition ... Composition #Plasma #comparison ... Effects #nephrology #pharmacology
Crystalloid Fluids - Contents Comparison Table
Normal plasma
0.9% saline (a.k.a. "normal saline" or NS)
0.45% saline (a.k.a. 1/2
Crystalloid Fluids ... - Contents Comparison ... 2 4NS + 20 meq KCL ... #Crystalloid #Fluids ... #Table #pharmacology
Intern Pocket Cards - Antibiogram and Susceptibilities
VRE - MRSA - GRAM POSITIVES - GRAM NEGATIVES -
Pocket Cards - Antibiogram ... (IV or PO?) ... If on IV, can I ... Susceptibilities #antibiotics ... #management #pharmacology
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... PO (or 400 mg IV ... if MIC<0.12 ug/ml ... Enteric #Bacterial #IDSA ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... 100 cells/mm3 g/mL ... to 5 mg/kg/day IV ... Penicilliosis #IDSA ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... suspension 4–6 mL ... 400 mg) PO or IV ... candida #mucosal #IDSA ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Isospora belli Infection in HIV-AIDS
Treating Isospora belli Infection
General Management Considerations:
 • Fluid
IDSA Recommendations ... Considerations: • Fluid ... 800 mg) PO (or IV ... IsosporaBelli #IDSA ... infections #HIVAIDS #pharmacology